Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program

Journal of the American Pharmacists Association

Volumn 48, Issue 6, 2008, Pages 731-736

  DeName, Bridger ^a,b   Divine, Holly ^b   Nicholas, Amy ^b   Steinke, Douglas T ^b   Johnson, Carrie L ^b  

^a Kroger Pharmacy   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Collaboration; Drug therapy problems; Medication therapy management; Pharmaceutical care

Indexed keywords

AGED; AMBULATORY CARE; ARTICLE; COST CONTROL; ECONOMICS; FEMALE; HEALTH INSURANCE; HEALTH PERSONNEL ATTITUDE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PHYSICIAN; PROFESSIONAL STANDARD; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PUBLICATION; TIME; UNITED STATES;

AGED; AMBULATORY CARE; ATTITUDE OF HEALTH PERSONNEL; COST SAVINGS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FORMULARIES AS TOPIC; HUMANS; INSURANCE, HEALTH; KENTUCKY; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 59049101783     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07070     Document Type: Article

References (27)

1. hayes BD, Klein-Schwartz W, Barrueto F. Polypharmacy and the geriatric patient. Clin Geriatr med. 2007;23:371-90.
2. Jyrkka J, vartiainen L, hartikainen S, et al. Increasing use of medications in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151-8.
3. isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch intern med. 2003;163:1813-20.
4. Ellis SL, Billups SJ, malone DC, et al. Types of interventions made by clinical pharmacists in the imPRovE study. Pharmacotherapy. 2000;20:429-35.
5. Berringer R, Shibley MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
6. Bluml BM, mcKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project imPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
7. Doucette WR, mcDonough RP, Klepser D, mcCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104-11.
8. Lapane KL, hughes CM. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase iii study: the role of process control. Ann Pharmacother. 2006;40:1522-6.
9. hatoum HT, Witte KW, hutchinson RA. Patient care contributions of clinical pharmacists in four ambulatory care clinics. hosp Pharm. 1992;27:203-6, 208-9.
10. Dobie RL, Rascati KL. Documenting the value of pharmacist interventions. Am Pharm. 1994;NS34(5):50-4.
11. Forstrom MJ, Ried LD, Stergachis AS, et al. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. Ann Pharmacother. 1990;24:304-9.
12. Jameson J, vanNoord G, vanderwoud K. The impact of the pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995;41:469-72.
13. munroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113-23.
14. Johnson CL, Nicholas A, Divine H, et al. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc. 2008;48:722-730.
15. Divine H, Nicholas A, Johnson CL, et al. PharmacistCARE: description of a pharmacist care service and lessons learned along the way. J Am Pharm Assoc. 2008;48:793-802.
16. Nicholas AS, Divine HS, Nowak-Rapp M, Roberts KB. University and college of pharmacy collaboration to control health plan prescription drug costs. J Am Pharm Assoc. 2007;47:86-92.
17. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist's activities: back to basics. Drug Intell Clin Pharm. 1988;22:63-7.
18. Kuperman GJ, Bobb A, Payne TH, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc. 2007;14:29-40.
19. Dufour JC, Bouvenot J, Ambrosi P, et al. Textual guidelines versus computable guidelines: a comparative study in the framework of the PRESGUID project in order to appreciate the impact of guideline format on physician compliance. AMIA Annu Symp Proc. 2006;219-23.
20. Tamblyn R. Improving patient safety through computerized drug management: the devil is in the details. Healthc Pap. 2004;5(3):52-68.
21. Fretheim A, Oxman AD, Treweek S, Bjorndal A. Rational prescribing in primary care (RaPP-trial): a randomized trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice. BMC Health Serv Res. 2003;3:5.
22. Cutler TW, Palmieri J, Khalsa M, Stebbins M. Evaluation of the relationship between a chronic disease care management program and California pay-for-performance diabetes care cholesterol measures in one medical group. J Manag Care Pharm. 2007;13:578-88.
23. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-34.
24. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care: a pilot study. Pharm World Sci. 2005:202-7.
25. Salisbury C, Fahey T. Overcoming clinical inertia in the management of hypertension. CMAJ. 2006;174:1267-71.
26. Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285:182-9.
27. Gilmer TP, O'Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care. 1997;20:1847-53.